129 related articles for article (PubMed ID: 14902588)
1. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
HANSEN PB; BICHEL J
Acta radiol; 1951 Dec; 36(6):469-76. PubMed ID: 14902588
[No Abstract] [Full Text] [Related]
2. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
HANSEN PB; BICHEL J
Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945
[No Abstract] [Full Text] [Related]
3. [Triethylene melamine in Hodgkin's disease].
HOST H; QVIGSTAD G
Nord Med; 1955 Sep; 54(36):1383-5. PubMed ID: 13266133
[No Abstract] [Full Text] [Related]
4. Observations on the use of triethylene melamine in Hodgkin's disease.
DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
[No Abstract] [Full Text] [Related]
5. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas.
ROTTINO A
N Y State J Med; 1952 Feb; 52(3):346-8. PubMed ID: 14899689
[No Abstract] [Full Text] [Related]
6. Triethylene melamine in human malignant disease; results with oral administration of enteric-coated tablets.
PATERSON E; KUNKLER PB; WALPOLE AL
Br Med J; 1953 Jan; 1(4801):59-64. PubMed ID: 12997844
[No Abstract] [Full Text] [Related]
7. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
HAMBLY CK; ROBERTSON TI
Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
[No Abstract] [Full Text] [Related]
8. [The therapeutic effect of triethylene melamine in hemoblastosis].
SCHULZE E; FRANKE R; THIELE FH
Arztl Wochensch; 1953 Jul; 8(29):690-4. PubMed ID: 13080055
[No Abstract] [Full Text] [Related]
9. Treatment of lymphomatous diseases with triethylene melamine.
MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I
Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963
[No Abstract] [Full Text] [Related]
10. TRIETHYLENE-MELAMINE.
Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
[No Abstract] [Full Text] [Related]
11. Triethylene melamine in the treatment of neoplastic disease.
RUNDLES RW; BARTON WB
Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
[No Abstract] [Full Text] [Related]
12. [Immediate results of triethylene melamine therapy of neoplastic diseases].
LENTI G; GAVOSTO F
Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386
[No Abstract] [Full Text] [Related]
13. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
14. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report].
BOLIO MONSREAL E
Bol Liga Contra Cancer Havana; 1953 Jun; 28(3):56-62. PubMed ID: 13115509
[No Abstract] [Full Text] [Related]
15. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
NEUMANN C
Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
[No Abstract] [Full Text] [Related]
16. The clinical use of triethylene melamine.
KRAVITZ SC; DIAMOND HD; CRAVER LF
Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
[No Abstract] [Full Text] [Related]
17. HODGKIN'S disease: diagnosis and treatment.
Med J Aust; 1953 Jun; 1(26):934-5. PubMed ID: 13070940
[No Abstract] [Full Text] [Related]
18. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].
GARCIGA CE
Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241
[No Abstract] [Full Text] [Related]
19. [Triethylenemelanine in the treatment of lymphogranulomatoses and hemoblastoses].
WINKLER A; CERNY V
Cesk Onkol; 1954; 1(1):30-8. PubMed ID: 14390616
[No Abstract] [Full Text] [Related]
20. [Diagnosis and therapy of Hodgkin's disease; study of 110 cases].
JUSTIN-BESANCON L; LAMOTTE-BARRILLON S; DEBRAY J
Sem Hop; 1952 Dec; 28(95):3855-71. PubMed ID: 13048712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
